e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
COPD - health-related quality of life and patients' needs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of anxiety and depression in COPD: are females at higher risk?
M. Verga, F. Di Marco, M. Reggente, F. Casanova, P. Santus, B. Boveri, S. Pizzolato, S. Centanni (Milan, Italy)
Source:
Annual Congress 2005 - COPD - health-related quality of life and patients' needs
Session:
COPD - health-related quality of life and patients' needs
Session type:
Thematic Poster Session
Number:
3349
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Verga, F. Di Marco, M. Reggente, F. Casanova, P. Santus, B. Boveri, S. Pizzolato, S. Centanni (Milan, Italy). Prevalence of anxiety and depression in COPD: are females at higher risk?. Eur Respir J 2005; 26: Suppl. 49, 3349
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
High prevalence of current smokers among COPD patients with anxiety and depression symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001
Anxiety and depression in COPD patients: prevalence and risk factors
Source: Eur Respir J 2004; 24: Suppl. 48, 293s
Year: 2004
Prevalence and risk factors of depression in patients with COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Prevalence and impact of depression on COPD
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Smoking status and levels of anxiety and depression in hospitalized patients.
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018
The prevalence of anxiety and depression in a COPD outreach population
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005
Smoking, anxiety and depression in relation to chronic respiratory diseases: results of population survey ROSEPID
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009
Effect of depression and anxiety on the risk of exacerbation and hospitalization in COPD
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Prevalence depression – Anxiety and impact on quality of life, asthma control and asthma severity in adult patients with asthma
Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control
Year: 2011
Do anxiety and depression affect patients‘ perceived level of asthma control?
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008
Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Prevalence and characteristics of anxiety and depression in patients with advanced COPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
The impact of depression and anxiety on never-smokers COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Relationship between respiratory symptoms (and diagnosis), anxiety or depression and smoking cigarettes: a population-based study
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002
The combined association of anxiety or depression symptoms and obesity with incident asthma: The HUNT study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Chronic insomnia as a risk to somatic and mental health: do the different types of insomnia symptoms make a difference?
Source: Sleep and Breathing Conference 2021
Year: 2021
Emotional distress in children with problematic severe asthma is associated with parental anxiety and depression
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003
Management of depression and anxiety in COPD
Source: Eur Respir Mon 2013; 59: 144-163
Year: 2013
Prevalence of psychiatric disorders in seriously-ill COPD patients
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept